United States · Pharmaceuticals startup

Avanir Pharmaceuticals

Avanir Pharmaceuticals is a biopharmaceutical company focused on providing medicines to patients with central nervous system disorders.

Funding reportedLast round: Post ipo debt

PharmaceuticalsAliso Viejo, United States

What company datasets say Avanir Pharmaceuticals raised

Funding, as reported

Reported in all$46Min dollars
Rounds2
Last roundPost ipo debt
Last round dateJun 2012
Investors listed4

How it ended, so far

Exit

ExitBuyerPriceWhen
AcquiredOtsuka Pharmaceutical$3.5BDec 2014

Pharmaceuticals in United States

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Avanir Pharmaceuticals in front of investors. Or tell us what we have wrong.